|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1989-8-18
|
|
pubmed:abstractText |
A patient with hypogonadotropic hypogonadism owing to endogenous gonadotropin releasing hormone deficiency, who developed Hodgkin's disease is described. Chemotherapy administration caused prolonged and life-threatening myelosuppression; androgen substitution seemed to reverse bone marrow function and to maintain normal peripheral blood counts. Whether or not androgens are a necessary substitution in hypogonadal patients suffering from cancer and undergoing chemotherapy is discussed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0098-1532
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
222-6
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:2664441-Aged,
pubmed-meshheading:2664441-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:2664441-Bone Marrow,
pubmed-meshheading:2664441-Bone Marrow Diseases,
pubmed-meshheading:2664441-Hodgkin Disease,
pubmed-meshheading:2664441-Humans,
pubmed-meshheading:2664441-Hypogonadism,
pubmed-meshheading:2664441-Male,
pubmed-meshheading:2664441-Mechlorethamine,
pubmed-meshheading:2664441-Pituitary Hormone-Releasing Hormones,
pubmed-meshheading:2664441-Prednisone,
pubmed-meshheading:2664441-Procarbazine,
pubmed-meshheading:2664441-Testosterone,
pubmed-meshheading:2664441-Vincristine
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases?
|
|
pubmed:affiliation |
Department of Medicine, Hippocration General Hospital, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
